Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,989 | 46,832 | 36,810 | 30,159 | 35,627 |
| Marketable Securities | 62,876 | 79,777 | 106,559 | 118,989 | 135,930 |
| TOTAL | $122,252 | $132,153 | $148,404 | $154,947 | $178,306 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 9,443 | 22,797 | 48,795 | 59,968 |
| Other Non-Current Assets | 581 | 625 | 696 | 736 | 718 |
| TOTAL | $581 | $10,068 | $23,493 | $49,531 | $60,686 |
| Total Assets | $122,833 | $142,221 | $171,897 | $204,478 | $238,992 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,765 | 3,598 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 554 | 682 | 2,103 | 1,056 | 5,648 |
| Accrued Expenses | 20,688 | 17,676 | 22,758 | 18,259 | 21,959 |
| TOTAL | $30,007 | $21,956 | $24,861 | $19,315 | $27,607 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,396 | 27,053 | 29,882 | 29,528 | 29,419 |
| Other Non-Current Liabilities | 0 | 39 | 77 | 114 | 150 |
| TOTAL | $22,396 | $27,092 | $29,959 | $29,642 | $29,569 |
| Total Liabilities | $52,403 | $49,048 | $54,820 | $48,957 | $57,176 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,213 | 60,573 | 60,573 | 60,573 | 60,573 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -446,462 | -421,324 | -394,873 | -353,923 | -325,127 |
| Other shareholders' equity | 83 | 109 | 23 | 15 | -48 |
| TOTAL | $70,430 | $93,173 | $117,077 | $155,521 | $181,816 |
| Total Liabilities And Equity | $122,833 | $142,221 | $171,897 | $204,478 | $238,992 |